{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=ProAir%C2%AE+HFA", "query": { "intervention": "ProAir® HFA" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 21, "total_pages": 3, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=ProAir%C2%AE+HFA&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-03T20:53:19.245Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02040766", "title": "A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants Ages 4-11 Years Old With Persistent Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Beclomethasone dipropionate BAI", "type": "DRUG" }, { "name": "Placebo BAI", "type": "DRUG" }, { "name": "albuterol/salbutamol 90 mcg", "type": "DRUG" }, { "name": "Beclomethasone dipropionate MDI", "type": "DRUG" }, { "name": "Placebo MDI", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Teva Branded Pharmaceutical Products R&D, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "4 Years", "maximum_age": "11 Years", "sex": "ALL", "summary": "4 Years to 11 Years" }, "enrollment_count": 628, "start_date": "2013-12", "completion_date": "2016-03", "has_results": true, "last_update_posted_date": "2021-11-09", "last_synced_at": "2026-09-03T20:53:19.245Z", "location_count": 75, "location_summary": "Hoover, Alabama • Montgomery, Alabama • Phoenix, Arizona + 62 more", "locations": [ { "city": "Hoover", "state": "Alabama" }, { "city": "Montgomery", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Costa Mesa", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02040766" }, { "nct_id": "NCT03371459", "title": "Assessment of the Safety, Efficacy, PK, and Extrapulmonary Pharmacodynamics (PD) of Albuterol Sulfate Pressurized Inhalation Suspension (Hereafter Referred to as AS MDI) Compared to Proventil as an Active Control in Subjects With Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "AS MDI", "type": "DRUG" }, { "name": "Proventil", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 46, "start_date": "2017-12-29", "completion_date": "2018-03-26", "has_results": true, "last_update_posted_date": "2019-07-23", "last_synced_at": "2026-09-03T20:53:19.245Z", "location_count": 5, "location_summary": "Winter Park, Florida • North Dartmouth, Massachusetts • St Louis, Missouri + 2 more", "locations": [ { "city": "Winter Park", "state": "Florida" }, { "city": "North Dartmouth", "state": "Massachusetts" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Raleigh", "state": "North Carolina" }, { "city": "Medford", "state": "Oregon" } ], "official_url": "https://clinicaltrials.gov/study/NCT03371459" }, { "nct_id": "NCT01844401", "title": "Pharmacokinetic and Pharmacodynamic Profiles of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients With Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Albuterol Spiromax®", "type": "DRUG" }, { "name": "ProAir® HFA", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Teva Branded Pharmaceutical Products R&D, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "4 Years", "maximum_age": "11 Years", "sex": "ALL", "summary": "4 Years to 11 Years" }, "enrollment_count": 15, "start_date": "2013-04", "completion_date": "2013-10", "has_results": false, "last_update_posted_date": "2013-11-14", "last_synced_at": "2026-09-03T20:53:19.245Z", "location_count": 1, "location_summary": "Costa Mesa, California", "locations": [ { "city": "Costa Mesa", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01844401" }, { "nct_id": "NCT03549897", "title": "Bronchoprovocation Study to Evaluate the Pharmacodynamics of Albuterol Sulfate Inhalation Aerosol, eq 90 mcg Base", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "90 mcg Reference Product", "type": "DRUG" }, { "name": "180 mcg Reference Product", "type": "DRUG" }, { "name": "90 mcg Test Product", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Amneal Ireland Limited", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 100, "start_date": "2018-03-16", "completion_date": "2018-09", "has_results": false, "last_update_posted_date": "2018-06-14", "last_synced_at": "2026-09-03T20:53:19.245Z", "location_count": 1, "location_summary": "Brookhaven, New York", "locations": [ { "city": "Brookhaven", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT03549897" }, { "nct_id": "NCT00400608", "title": "A Study In Pediatric Subjects With Asthma Using ADVAIR HFA, ADVAIR HFA With Spacer, And ADVAIR DISKUS", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "ADVAIR HFA", "type": "DRUG" }, { "name": "ADVAIR DISKUS", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "4 Years", "maximum_age": "11 Years", "sex": "ALL", "summary": "4 Years to 11 Years" }, "enrollment_count": 28, "start_date": "2006-10", "completion_date": "2007-02", "has_results": false, "last_update_posted_date": "2016-10-28", "last_synced_at": "2026-09-03T20:53:19.245Z", "location_count": 3, "location_summary": "Huntington Beach, California • Long Beach, California • Medford, Oregon", "locations": [ { "city": "Huntington Beach", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Medford", "state": "Oregon" } ], "official_url": "https://clinicaltrials.gov/study/NCT00400608" }, { "nct_id": "NCT03364608", "title": "Study to Compare PT007 to Placebo MDI and Open-Label Proventil® HFA in Adult and Adolescent Subjects With Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "AS MDI 90 μg", "type": "DRUG" }, { "name": "AS MDI 180 µg", "type": "DRUG" }, { "name": "Placebo MDI", "type": "OTHER" }, { "name": "Proventil 90 μg", "type": "DRUG" }, { "name": "Proventil 180 μg", "type": "DRUG" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "12 Years to 65 Years" }, "enrollment_count": 86, "start_date": "2017-12-15", "completion_date": "2018-03-30", "has_results": true, "last_update_posted_date": "2019-07-24", "last_synced_at": "2026-09-03T20:53:19.245Z", "location_count": 10, "location_summary": "Rolling Hills Estates, California • Stockton, California • Winter Park, Florida + 7 more", "locations": [ { "city": "Rolling Hills Estates", "state": "California" }, { "city": "Stockton", "state": "California" }, { "city": "Winter Park", "state": "Florida" }, { "city": "North Dartmouth", "state": "Massachusetts" }, { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT03364608" }, { "nct_id": "NCT06473779", "title": "Open-label Study to Assess Reduction of Background Asthma Medication While Sustaining Asthma Control and Clinical Remission With Tezepelumab in Patients 12-80yrs With Severe Asthma.", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Severe Asthma" ], "interventions": [ { "name": "Tezepelumab", "type": "COMBINATION_PRODUCT" }, { "name": "Budesonide/formoterol", "type": "COMBINATION_PRODUCT" }, { "name": "Albuterol/budesonide (AIRSUPRA®)", "type": "COMBINATION_PRODUCT" }, { "name": "Mannitol", "type": "COMBINATION_PRODUCT" }, { "name": "Salbutamol", "type": "COMBINATION_PRODUCT" } ], "intervention_types": [ "COMBINATION_PRODUCT" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "12 Years to 80 Years" }, "enrollment_count": 326, "start_date": "2024-09-30", "completion_date": "2027-06-25", "has_results": false, "last_update_posted_date": "2026-06-15", "last_synced_at": "2026-09-03T20:53:19.245Z", "location_count": 8, "location_summary": "Palmdale, California • Colorado Springs, Colorado • Miami, Florida + 5 more", "locations": [ { "city": "Palmdale", "state": "California" }, { "city": "Colorado Springs", "state": "Colorado" }, { "city": "Miami", "state": "Florida" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT06473779" }, { "nct_id": "NCT01899144", "title": "Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Albuterol Spiromax", "type": "DRUG" }, { "name": "ProAir HFA", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Teva Branded Pharmaceutical Products R&D, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "4 Years", "maximum_age": "11 Years", "sex": "ALL", "summary": "4 Years to 11 Years" }, "enrollment_count": 61, "start_date": "2013-07", "completion_date": "2013-10", "has_results": true, "last_update_posted_date": "2022-01-26", "last_synced_at": "2026-09-03T20:53:19.245Z", "location_count": 22, "location_summary": "Birmingham, Alabama • Little Rock, Alaska • Costa Mesa, California + 19 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Little Rock", "state": "Alaska" }, { "city": "Costa Mesa", "state": "California" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Orange", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01899144" }, { "nct_id": "NCT02126839", "title": "A Chronic-Dose Safety and Efficacy Study of Albuterol Multi-Dose Dry Powder Inhaler in Pediatric Asthmatics", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Albuterol MDPI", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "ProAir HFA inhaler", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Teva Branded Pharmaceutical Products R&D, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "4 Years", "maximum_age": "11 Years", "sex": "ALL", "summary": "4 Years to 11 Years" }, "enrollment_count": 186, "start_date": "2014-05", "completion_date": "2015-02", "has_results": true, "last_update_posted_date": "2021-11-09", "last_synced_at": "2026-09-03T20:53:19.245Z", "location_count": 51, "location_summary": "Birmingham, Alabama • Mobile, Alabama • Little Rock, Alaska + 45 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Little Rock", "state": "Alaska" }, { "city": "Anaheim", "state": "California" }, { "city": "Costa Mesa", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02126839" }, { "nct_id": "NCT00577655", "title": "Albuterol HFA MDI in Pediatric Participants With Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Albuterol", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Proventil® HFA", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Teva Branded Pharmaceutical Products R&D, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "4 Years", "maximum_age": "11 Years", "sex": "ALL", "summary": "4 Years to 11 Years" }, "enrollment_count": 103, "start_date": "2007-08", "completion_date": "2008-07", "has_results": true, "last_update_posted_date": "2021-11-12", "last_synced_at": "2026-09-03T20:53:19.245Z", "location_count": 13, "location_summary": "Huntington Beach, California • Palmdale, California • Paramount, California + 10 more", "locations": [ { "city": "Huntington Beach", "state": "California" }, { "city": "Palmdale", "state": "California" }, { "city": "Paramount", "state": "California" }, { "city": "Riverside", "state": "California" }, { "city": "Sacramento", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00577655" } ] }